CRISPR-GNDM
LIVE

Serial Number

79275387

Owner

Modalis Therapeutics Corporation

Attorney

Anne E. Naffziger

Filing Date

Nov 15, 2019

Add to watchlist:

No watchlists yet
View on USPTO

CRISPR-GNDM Trademark

Serial Number: 79275387 • Registration: 6311279

CRISPR-GNDM is a trademark filed by Modalis Therapeutics Corporation on November 15, 2019. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Modalis Therapeutics Corporation (2 trademarks)

3-11-5, Nihonbashi-Honcho,

Entity Type: 03

Trademark Details

Filing Date

November 15, 2019

Registration Date

April 6, 2021

Published for Opposition

October 20, 2020

Goods & Services

Testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs

Reagents for research purposes

Pharmaceutical preparations for gene therapy; reagent paper for medical purposes

Providing medical information; physical examination

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Apr 6, 2026 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 7, 2021 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jul 21, 2021 FICS
FINAL DISPOSITION PROCESSED
Jul 21, 2021 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 6, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Apr 6, 2021 R.PR
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Feb 28, 2021 ETOP
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jan 29, 2021 ADCH
EXTENSION OF TIME TO OPPOSE RECEIVED
Nov 18, 2020 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 20, 2020 NPUB
PUBLISHED FOR OPPOSITION
Oct 20, 2020 PUBO
NOTIFICATION PROCESSED BY IB
Oct 18, 2020 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 30, 2020 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Sep 30, 2020 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 30, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 15, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 10, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 9, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 9, 2020 TROA
REFUSAL PROCESSED BY IB
Apr 3, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 19, 2020 RFCS
REFUSAL PROCESSED BY MPU
Mar 19, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 29, 2020 RFCR
NON-FINAL ACTION WRITTEN
Feb 28, 2020 CNRT
ASSIGNED TO EXAMINER
Feb 19, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 11, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 7, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 2, 2020 REPR